Pretzel Therapeutics (Biotechnology, Health and Wellness) — Funding, Investors & Signals 2026

Pretzel Therapeutics

Welcome to a new era in mitochondrial therapeutics

Founded 2019

Boston, United States 46 employees Series A Total: $72.50M Biotechnology, Health and Wellness +1

Pretzel Therapeutics is a biotechnology and pharmaceutical startup established in 2019, headquartered in the United States. With the slogan "Welcome to a new era in mitochondrial therapeutics," Pretzel Therapeutics is on a mission to develop groundbreaking therapies to reverse mitochondrial dysfunction. Mitochondria, the energy-converting cellular organelles, are implicated in over 50 diseases, including rare genetic conditions and aging-related disorders. The startup aims to target the genetic drivers of mitochondrial dysfunction, potentially offering effective treatment options across a wide range of diseases that currently lack meaningful solutions. The company recently secured a significant $72.50M Series A investment on 12 September 2022. The investment was led by a notable group of investors including Arch Venture Partners, GV, HealthCap, Invus, Angelini Ventures, Eir Ventures, GU Ventures, University of Cambridge Enterprise, Karolinska, and Mubadala Capital Ventures. This substantial investment reflects the confidence of prominent venture capital firms in the potential of Pretzel Therapeutics' innovative approach to address mitochondrial dysfunction. Overall, Pretzel Therapeutics is positioned at the forefront of mitochondrial therapeutics, with a promising focus on addressing crucial medical needs through its pioneering research and development efforts. With the recent major investment, the company is well-positioned to advance its mission and potentially make significant strides in the treatment of mitochondrial-related diseases.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	••••••	10	•••• ••••	12 Sep 2022
Venture Round	••••••	-		10 Oct 2021

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

••••••

•••• ••••

12 Sep 2022

Venture Round

••••••

10 Oct 2021

FAQ About Pretzel Therapeutics

Welcome to a new era in mitochondrial therapeutics

Pretzel Therapeutics was founded in 2019.

Pretzel Therapeutics is headquartered in Boston, United States.

Pretzel Therapeutics operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.

Pretzel Therapeutics has approximately 46 employees.

Pretzel Therapeutics has completed 2 funding rounds, raising a total of $72.50M. The latest funding stage is Series A.

Top alternatives and competitors to Pretzel Therapeutics include Minovia Therapeutics , Stealth BioTherapeutics, Mitochon Pharmaceuticals, Inc., Reneo Pharmaceuticals, OMEICOS Therapeutics GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Pretzel Therapeutics and Minovia Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Pretzel Therapeutics

General Information

Track Pretzel Therapeutics

Discover More

About Pretzel Therapeutics

Funding Rounds & Investors (2)

Pretzel Therapeutics Alternatives & Competitors

FAQ About Pretzel Therapeutics

Don't just browse. Track.